To screen for lung cancer, or not to screen? That is the question that referring clinicians across the country face in the wake of the National Lung Screening Trial (NLST). While radiologists may be ideally situated to help physicians wade through the nuances of the question, a group of clinicians debated the question in two articles published online Sept. 5 in Annals of Internal Medicine.

Compared with changes in biomarkers, changes in cognitive abilities appear to be stronger predictors of whether an individual with mild cognitive impairment (MCI) will develop Alzheimers disease, based on research published in the September issue of Archives of General Psychiatry.

A patient-specific, 3D dosimetry protocol using the radiopharmaceutical Tc-HYNIC-TOC is clinically feasible to demonstrate large dose variations in neuroendocrine tumors and normal organs, according to study findings published Sept. 1 in the Journal of Nuclear Medicine.

Image-guided thermal ablation of lung malignancies is on the rise and appears to offer a safe choice for a subset of non-surgical candidates. However, additional clinical studies are needed to demonstrate the efficacy of the procedure in comparison with other treatments, according to a review article published in the September issue of Radiology.

The Centers for Disease Control and Prevention (CDC) has issued a checklist to help healthcare providers apply Guide to Infection Prevention in Outpatient Settings: Minimum Expectations for Safe Care.

The Society of Nuclear Medicine (SNM) has announced the recipients of the 2011-2013 SNM Wagner-Torizuka Fellowship, which is a two-year fellowship designed to provide extensive training and experience in the fields of nuclear medicine and molecular imaging for Japanese physicians in the early stages of their careers.

Aiming to ensure adequate protection of human subjects and the quality of clinical trial data, the FDA released draft guidance on the oversight of clinical investigations Aug. 29. The administration will be accepting public comment for 90 days on Guidance for Industry Oversight of Clinical InvestigationsA Risk-Based Approach to Monitoring.

As hospitals look for ways to simultaneously slash healthcare costs and improve care, transradial PCI could be on the forefront as a way to help curb costs and improve patient care. But despite the potential benefits, the procedure has had a slow adoption rate among interventionalists.